CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway

  • Fu Liu, Zhi Shangli, Zhili Hu
  • OncoTargets and Therapy, September 2018, Dove Medical Press
  • DOI: 10.2147/ott.s172803

The authors haven't yet claimed this publication.

open access logoRead Publication

http://dx.doi.org/10.2147/ott.s172803